Astec LifeSciences Limited has informed the Exchange about re-appointment of Ms. Anjali Gupte, as a Non-Executive & Independent Director of the Company for a second term of 5 (five) years commencing from 18th December, 2025 upto 17th December, 2030, subject to approval of the Shareholders
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astec LifeSciences has informed the exchange about the re-appointment of Ms. Anjali Gupte as a Non-Executive & Independent Director. This will be her second term on the board, lasting 5 years from 18th December 2025 to 17th December 2030. The re-appointment is subject to approval from shareholders. Ms. Gupte has already served one term as an independent director on the company's board.
This is a routine governance update signalling continuity on the board. The re-appointment of an existing independent director for a full second 5-year term is generally viewed as neutral to mildly positive for corporate governance stability. No material change in business direction is expected.